Olutasidenib Combination Therapy
A Phase 2 Study Evaluating Olutasidenib in Combination With Hypomethylating Agents in Patients With IDH1-mutated Higher-risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Advanced Myeloproliferative Neoplasm
Arms / Cohorts
Experimental:Olutasidenib + Azacitidine
Accepting patients
Experimental:Olutasidenib + Decitabine
Accepting patients
Experimental:Olutasidenib + Decitabine/Cedazuridine
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.